OmniComm Systems, Inc. (OTCQB: OMCM) is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials.
Provided below are links to our financial statements as filed with the United States Securities and Exchange Commission
The OmniComm Systems, Inc. 2017 Annual Meeting of Stockholders will be held on June 22, 2017.
To learn more about this dynamic company and related investment opportunities, please contact our financial team by email at [email protected]